DS-8201a
UC-GMP-2402
Phase 2 small_molecule active
Quick answer
DS-8201a for Metastatic Breast Cancer HR+, HER2- is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Metastatic Breast Cancer HR+, HER2-
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active